DelSiTech is a technology platform company specializing in long-acting formulations, dedicated to transforming the treatment landscape in the areas of metabolic disease and pain through our lead long-acting injectable assets. DelSiTech aims to deliver new therapeutic products that offer better patient adherence and reduced dosing frequency through long-acting injectables, with the potential to support improved therapeutic outcomes.
